Huma Qamar

Huma Qamar

Auto-generated profile, based on publicly available information

Huma Qamar

Centre for Global Child Health and SickKids Research Institute, Hospital for Sick Children, Toronto, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
AAAshley M. Aimone
Ashley M. Aimone
DBDiego G. Bassani
Diego G. Bassani
HQHuma Qamar
Huma Qamar
ADAlison Dasiewicz
Alison Dasiewicz
NPNandita Perumal
Nandita Perumal
DRDaniel Roth
Daniel Roth
Stunting prevalence is commonly used to track population-level child nutritional status. However, other metrics derived from anthropometric datasets may be used as alternatives to stunting or provide complementary perspectives on the status of linear growth faltering in low- and middle-income countries (LMICs). Data from 156 Demographic and Health Surveys in 63 LMICs (years 2000 to 2020) were used to generate 2 types of linear growth metrics: (i) measures of location of height distributions (including stunting) for under-5 years (<5y) and 2 to 5 years (2-5y); (ii) model-derived metrics including predicted mean height-for-age z-score (HAZ) at 0, 2, and 5 years; interval slopes of HAZ, height-for-age difference (HAD), and growth delay (GD) from 1 month to 2 years (1mo-2y) and 2-5y; and the SITAR intensity parameter (SITAR-IP) for <5y. Using Spearman’s rank correlation coefficient (r), metrics were considered alternatives to stunting if very strongly correlated with stunting (|r|≥0.95) and at least as strongly correlated as stunting with selected population indicators (under 5y mortality, gross domestic product, maternal education). Metrics were considered complementary if less strongly correlated with stunting (|r|<0.95) yet correlated with population indicators. We identified 6 of 15 candidate metrics (stunting 2-5y, mean HAZ <5y and 2-5y, p25 HAZ <5y and 2-5y, predicted HAZ at 2y) as potential alternatives to stunting and 6 as complementary metrics (SITAR-IP, predicted HAZ at 5y, HAZ slope 1m-2y, HAD slope 1m-2y, GD slopes 1m-2y and 2-5y). Three metrics (HAZ slope 2-5y, HAD slope 2-5y years and predicted HAZ at birth) had weak correlations with population indicators (|r| ≤ 0.43). In conclusion, several linear growth metrics could serve as alternatives to stunting prevalence and others may be complementary to stunting in tracking global progress in child health and nutrition. Further research is needed to explore the real-world utility of these alternative and complementary metrics.

30 April 2021 in Current Developments in Nutrition
Verified
Journal Article
Open access
PDF file
SSSarah L Silverberg
Sarah L Silverberg
HQHuma Qamar
Huma Qamar
FKFarhana K Keya
Farhana K Keya
SSShaila S Shanta
Shaila S Shanta
MIM Munirul Islam
M Munirul Islam
DRDaniel Roth
Daniel Roth
Causes of infant linear growth faltering in low-income settings remain poorly understood. Identifying age-specific risk factors in observational studies might be influenced by statistical model selection. To estimate associations of selected household factors and infant feeding behaviors within discrete age intervals with interval-specific changes in length-for-age z-scores (LAZs) or attained LAZ, using 5 statistical approaches. Data from a birth cohort in Dhaka, Bangladesh (n = 1157) were analyzed. Multivariable-adjusted associations of infant feeding patterns or household factors with conditional LAZ (cLAZ) were estimated for 5 intervals in infancy. Two alternative approaches were used to estimate differences in interval changes in LAZ, and differences in end-interval attained LAZ and RRs of stunting (LAZ < −2) were estimated. LAZ was symmetrically distributed with mean ± SD = −0.95 ± 1.02 at birth and −1.00 ± 1.04 at 12 mo. Compared with exclusively breastfed infants, partial breastfeeding (difference in cLAZ: −0.11; 95% CI: −0.20, −0.02) or no breastfeeding (−0.30; 95% CI: −0.54, −0.07) were associated with slower growth from 0 to 3 mo. However, associations were not sustained beyond 6 mo. Modifiable household factors (smoking, water treatment, soap at handwashing station) were not associated with infant growth, attained size, or stunting. Alternative statistical approaches yielded mostly similar results as conditional growth models. The entire infant LAZ distribution was shifted down, indicating that length deficits were mostly caused by ubiquitous or community-level factors. Early-infant feeding practices explained minimal variation in early growth, and associations were not sustained to 12 mo of age. Statistical model choice did not substantially alter the conclusions. Modifications of household hygiene, smoking, or early infant feeding practices would be unlikely to improve infant linear growth in Bangladesh or other settings where growth faltering is widespread.

24 July 2021 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
BLBenjamin Levy
Benjamin Levy
KOKaren M O'CAllaghan
Karen M O'CAllaghan
HQHuma Qamar
Huma Qamar
AMAbdullah Al Mahmud
Abdullah Al Mahmud
AGAlison Gernand
Alison Gernand
DRDaniel Roth
Daniel Roth
Variability in the 25-hydroxyvitamin D [25(OH)D] response to prenatal and postpartum vitamin D supplementation is an important consideration for establishing vitamin D deficiency prevention regimens. We aimed to examine interindividual variation in maternal and infant 25(OH)D following maternal vitamin D supplementation. In a randomized trial of maternal vitamin D supplementation (Maternal Vitamin D for Infant Growth Trial), healthy pregnant women (n = 1300) received a prenatal cholecalciferol (vitamin D-3) dose of 0, 4200, 16,800, or 28,000 IU/wk from 17 to 24 wk of gestation followed by placebo to 6 mo postpartum. A fifth group received 28,000 IU cholecalciferol/wk both prenatally and postpartum. In a subset of participants, associations of 25(OH)D with hypothesized explanatory factors were estimated in women at delivery (n = 655) and 6 mo postpartum (n = 566), and in their infants at birth (n = 502) and 6 mo of age (n = 215). Base models included initial 25(OH)D and supplemental vitamin D dose. Multivariable models were extended to include other individual characteristics and specimen-related factors. The model coefficient of determination (R2) was used to express the percentage of total variance explained. Supplemental vitamin D intake and initial 25(OH)D accounted for the majority of variance in maternal 25(OH)D at delivery and postpartum (R2 = 70% and 79%, respectively). Additional characteristics, including BMI, contributed negligibly to remaining variance (<5% increase in R2). Variance in neonatal 25(OH)D was explained mostly by maternal delivery 25(OH)D and prenatal vitamin D intake (R2 = 82%). Variance in 25(OH)D in later infancy could only partly be explained by numerous biological, sociodemographic, and laboratory-related characteristics, including feeding practices (R2 = 43%). Presupplementation 25(OH)D and vitamin D supplemental dose are the major determinants of the response to maternal prenatal vitamin D intake. Vitamin D dosing regimens to prevent maternal and infant vitamin D deficiency should take into consideration the mean 25(OH)D concentration of the target population.

1 March 2021 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
HQHuma Qamar
Huma Qamar
NPNandita Perumal
Nandita Perumal
EPEszter Papp
Eszter Papp
AGAlison D Gernand
Alison D Gernand
AMAbdullah Al Mahmud
Abdullah Al Mahmud
DRDaniel Roth
Daniel Roth
Intrauterine growth restriction (IUGR) reflects inadequate growth in-utero and is prevalent in low resource settings. This study aimed to assess the association of maternal delivery parathyroid hormone (PTH), a regulator of bone turnover and calcium homeostasis, with newborn anthropometry, to identify regulators of PTH, and to delineate pathways by which maternal PTH regulates birth size using path analysis. This was a cross-sectional analysis of data from participants (n=537) enrolled in the Maternal Vitamin D for Infant Growth trial in Dhaka, Bangladesh. Primary exposures were maternal delivery intact PTH (iPTH) or whole PTH (wPTH) and outcomes were gestational age- and sex-standardized z-scores for birth length (LAZ), weight (WAZ), and head circumference (HCAZ). Hypothesized regulators of PTH included calcium and protein intake, vitamin D, magnesium, fibroblast-like growth factor-23 (FGF23), and C-reactive protein. Maternal iPTH was not associated with birth size in linear regression analyses; however, in path analysis models, every SD increase in log[iPTH] was associated with 0.08SD (95% CI:0.002,0.162) higher LAZ. In linear regression and path analysis models, wPTH was positively associated with WAZ. Vitamin D suppressed PTH, while FGF23 was positively associated with PTH. In path analysis models, higher magnesium was negatively associated with LAZ; FGF23 was positively associated and protein intake was negatively associated with LAZ, WAZ, and HCAZ. Higher maternal PTH in late pregnancy is unlikely to contribute to IUGR. Future studies should investigate maternal FGF23, magnesium and protein intake as regulators of fetal growth, particularly in settings where food insecurity and IUGR are public health problems.

18 May 2020 in Social Anthropology/Anthropologie Sociale
Verified
Journal Article
Open access
PDF file
AAAnushka Ataullahjan
Anushka Ataullahjan
JKJean‐Luc Kortenaar
Jean‐Luc Kortenaar
HQHuma Qamar
Huma Qamar
Click on the article title to read more.

28 March 2026 in Nutrition
Verified
Journal Article
Open access
AKAfreen Z. Khan
Afreen Z. Khan
ARAnjan K. Roy
Anjan K. Roy
HQHuma Qamar
Huma Qamar
LPLisa G. Pell
Lisa G. Pell
KOKaren M. O’CAllaghan
Karen M. O’CAllaghan
RRRubhana Raqib
Rubhana Raqib
Probiotics may enhance host iron bioavailability, offering a strategy to address iron deficiency. Fecal iron may be a useful noninvasive biomarker of such effects in infants. To examine the use of fecal iron quantification in a randomized placebo-controlled trial (RCT) of neonatal administration of Lactiplantibacillus plantarum ATCC 202195 (LP202195), with or without fructooligosaccharide (FOS), in Dhaka, Bangladesh. Fecal iron quantification using atomic absorption spectrometry (AAS) was optimized using standards and reference materials, and pilot-tested using pooled stool aliquots (n = 32) from an observational cohort of young infants in Bangladesh (aged 0-64 days). The optimized AAS assay was then applied to individual stool samples collected at 14 days of age (n = 307) in a RCT in which newborns aged 0-4 days were randomly allocated to one of five groups: placebo, 1- or 7-day regimens of LP202195, with or without FOS. Serum ferritin was measured at 2 months postnatal age (n = 251). Effects of the 1- and 7-day LP202195 regimens were estimated using linear regression and expressed as mean percent differences relative to placebo, with 95% confidence intervals (95% CI). The optimized AAS fecal iron assay had acceptable accuracy (91%-99%), precision (within- and between-run coefficients of variation 0.05 for all). Similarly, there were no effects of LP202195 on serum ferritin at 2 months of age (P > 0.05 for all). Fecal iron quantification by AAS was valid and feasibly implemented in a trial of neonatal administration of L. plantarum ATCC 202195. However, the assay is resource-intensive and may not be more informative than conventional measures of iron status when studying the effects of probiotics/synbiotics on iron bioavailability. ClinicalTrials.gov identifier: NCT05180201.